As of 2026-01-19, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.92 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.28 USD, the upside of Design Therapeutics Inc is -163.80%.
Based on its market price of 9.28 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 163.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.92 - -5.92 | -5.92 | -163.80% |
| P/E | (18.19) - (19.47) | (18.65) | -301.0% |
| DDM - Stable | (14.84) - (71.78) | (43.31) | -566.7% |
| DDM - Multi | (0.18) - (0.66) | (0.29) | -103.1% |
| Market Cap (mil) | 528.59 |
| Beta | 0.56 |
| Outstanding shares (mil) | 56.96 |
| Enterprise Value (mil) | 513.50 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.54% |
| Cost of Debt | 5.00% |
| WACC | 5.71% |